EKNL super low float play with key partners just announced is making way for a MAJOR breakout run and we are on HIGH news alert that will definitely push prices to record levels.
We recently confirmed that the “active float” for EKNL is only 5.5 Million shares and in the hands of very strong investors not selling for anything less than our $1.25 target level.
With what EKNL has in store, insiders not selling a single share for less than dollar land, and institutional groups now looking at EKNL and it’s $1.25 price target, we are definitely going to see many more members become millionaires.
Healthy pause and consolidations add strength to a bullish run, just as we have seen last week when EKNL built support near $0.12 price level before breaking out to push to near record highs and where we sit now. Continue reading
HOT STOCK BREAKOUT ALERT FOR EKNL!
EKNL soared another 32% today on monster volumes and it definitely getting some attention now.
The last time we seen this breakout action was our 2011 Trophy winner Fuse Science (DROP). When DROP push over the $0.20 level it quickly jumped to $1.25 and EKNL is right on track with this breakout move!
It’s worth looking at again the comparison chart between DROP and EKNL which is lining up perfectly and we all know the HUGE breakout DROP had hitting our target price $1.25 dead on and 83,000% gains!
No doubt EKNL will be our trophy winner for 2012!
EKNL is breaking out big time closing above key levels and at it’s highest price of $0.206 since our initial alert at $0.04!
As we promised, EKNL will be our 2012 trophy winner and already performing even better than our 2011 Trophy Winner DROP (+83,000%) which ‘xploded’ at these similar key breakout levels to hit a high of $1.25
DROP has it’s Tiger Woods, but EKNL just announced partnership with Walmart and we expect a series of other MAJOR updates that will pale in comparison!
EKNL technical chart is set up perfectly and we are already seeing an initial breakout formation to push prices to record highs.
We already identified the bullish Flag pattern last week, and was confirmed with a monster breakout over the 200 DMA ($0.145). This confirms that bulls are in total control to move past historic highs in the near term.
EKNL unleashed a MONSTER update which just put them on a different playing field and definitely worth repeating again.
EKO, NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.
Unbelievable and when the market starts to get wind that EKNL is already providing 100 Walmart-Canada stores with Neurometrix NC-stat® | DPN Check™ testing units, prices will go insane.
We actually got a taste of it yesterday with EKNL closing at $0.18 up 38.46% on over 1 million shares traded.
This Monster update has prompted us to revisit our research report with initial target of $1.00 per share this weekend. Walmart is a HUGE addition to EKNL’s business plan that cannot be ignored. Continue reading
EKNL released a solid update yesterday and saying that it will be attending the 13th annual Medical Show in London – this is HUGE!
Also, Dr. Paul Ziemer of NCI and J.V partner with EKNL will working very close with Dr. Kenneth J. Snow of Neurometrix a Nasdaq public company (NURO).
This world renowned Medical show will give EKNL monster exposure with several key players working close with EKNL and their distribution of FREMS technology You can visit the events page here
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
NC-stat® | DPNCheck™ Continue reading
Add another solid day for EKNL and holding strong to 200% gains since our alert at $0.04 just a week ago. With several key updates already released by the company – this defines exactly what our ‘Core’ plays are all about.
Better yet, we will be profiling EKNL for the entire month leading into the recently announce 13th annual Medical Show in London this month.
This world renowned Medical show will give EKNL HUGE exposure with several key players working close with EKNL and their distribution of FREMS technology You can visit the events page here
Looking at the conference itinerary, Dr. Paul Ziemer of NCI will working very close with Dr. Kenneth J. Snow of Neurometrix a Nasdaq public company (NURO).
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. This is HUGE and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development. Continue reading